Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic
- 1 December 1995
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 115 (3) , 411-418
- https://doi.org/10.1017/s0950268800058568
Abstract
Summary: Vaccination againstNeisseria meningitidisis not part of routine immunization schemes in any country; instead, targeted vaccination of groups at the highest risk is recommended during outbreaks and epidemics. After a long period of sporadic occurrence of meningococcal invasive disease, a new clone ofNeisseria meningitidisC: 2a: P1.2, ET-15/37, occurred in the Czech Republic, and caused local outbreaks in two neighbouring districts, Olomouc and Bruntal, in spring 1993. In Olomouc, a mass campaign was conducted during which 6191 students were vaccinated (5·6 % of the total population of this locality and 96% of all students in the age group 15–19) within 2 weeks in June 1993. In Bruntal district, no such campaign was organized. In Olomouc, the incidence of invasive disease caused byNeisseria meningitidisC in the age group 10–24 decreased from 57 to 0 per 100000 (P < 0·001) during the post-vaccination period (July 1993–August 1994), but no such decrease was observed in Bruntal. Although other factors can affect the frequency of disease, these results support the current recommendations of targeted vaccination in outbreaks of meningococcal disease.Keywords
This publication has 45 references indexed in Scilit:
- Comparative Studies on Pharyngeal Carriage of Neisseria meningitidis during a Localized Outbreak of Serogroup C Meningococcal DiseaseScandinavian Journal of Infectious Diseases, 1993
- Vaccination campaign against meningococcal disease in army recruits in ItalyEpidemiology and Infection, 1990
- Definition of meningococcal class 1 OMP subtyping antigens by monoclonal antibodiesFEMS Microbiology Letters, 1988
- Mortality from meningococcal disease during an epidemic in The Gambia, West AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1987
- AGE-SPECIFIC DIFFERENCES IN DURATION OF CLINICAL PROTECTION AFTER VACCINATION WITH MENINGOCOCCAL POLYSACCHARIDE A VACCINEThe Lancet, 1985
- Serum Antibodies to Capsular Polysaccharide Vaccine of Group A Neisseria meningitidis Followed for Three Years in Infants and ChildrenThe Journal of Infectious Diseases, 1980
- CONTROL OF MENINGOCOCCAL INFECTION IN THE AFRICAN MENINGITIS BELT BY SELECTIVE VACCINATIONThe Lancet, 1980
- Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of AgeNew England Journal of Medicine, 1977
- Polysaccharide Vaccines of Group A Neisseria meningitidis and Haemophilus influenzae Type b: A Field Trial in FinlandThe Journal of Infectious Diseases, 1977
- EFFECT OF GROUP-A MENINGOCOCCAL VACCINE IN ARMY RECRUITS IN FINLANDThe Lancet, 1975